BIOFORCE NANOSCIENCES HOLDINGS, INC.
BFNH · OTCMCIK 1310488fmd_1FW6K7PJCGB206F1ZYD4YMKEMQManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2026, 37 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | – | – | – | – | – | – |
| Cost of revenue | 0 | 0 | 0 | – | – | – | – | – | – |
| Gross profit | 0 | 0 | 0 | – | – | – | – | – | – |
| Total operating expenses | – | – | 0 | 158 | 1 | 0 | 0 | 0 | 0 |
| Operating income | (0) | (0) | (0) | – | – | – | – | – | – |
| Income before taxes | (0) | (0) | (0) | – | – | – | – | (0) | (0) |
| Income tax expense | – | 0 | 0 | – | – | – | – | – | – |
| Net income from continuing operations | – | (0) | (0) | – | – | – | – | – | – |
| Net income | (0) | (0) | (0) | (158) | (1) | (0) | (0) | (0) | (1) |